Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast
- 10 September 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 136 (11) , 1368-1372
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Risk-reducing mastectomy in BRCA mutation carriers: survival is one of the issues—author's replyBreast Cancer Research and Treatment, 2019
- Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank ParticipantsJAMA Network Open, 2018
- Breast Implants and the Risk of Anaplastic Large-Cell Lymphoma in the BreastJAMA Oncology, 2018
- Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation CarriersJAMA, 2017
- Population Frequency of Germline BRCA1/2 MutationsJournal of Clinical Oncology, 2016
- ClinVar: public archive of interpretations of clinically relevant variantsNucleic Acids Research, 2015
- Breast Implant–Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 PatientsJournal of Clinical Oncology, 2014
- Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian DisordersNew England Journal of Medicine, 2013
- Anaplastic Large-Cell Lymphoma in Women With Breast ImplantsJAMA, 2008
- Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer casesBritish Journal of Cancer, 2000